Wen Tianfu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC Study) (NCT05738616) | Wen Tianfu | 2024-05-10 |
Track Wen Tianfu automatically
Every clearance here is in the API, with alerts when new ones post.